media – Page 656 – Pharma & Medical Industry Insights Hub | Drugdu Insights & Updates

People Who Sleep Less Than 8 Hours a Night More Likely to Suffer Anxiety and Depression

Binghampton University researchers report sleeping less than 8 hours a night can result in negative, repetitive thoughts associated with anxiety and depression.
- Source: neurosciencenews
- 498
- January 5, 2018
anxiety Depression Researches Sleep deprivation
US awards Novartis’ Kisqali ‘Breakthrough’ status

Novartis’ CDK4/6 inhibitor Kisqali has picked up Breakthrough status in the US as an initial endocrine-based treatment in certain patients with breast cancer.
- Source: pharmatimes
- 622
- January 4, 2018
inhibitor Kisqali New Approvals
Sangamo partners with Pfizer to develop gene therapy for ALS

Sangamo Therapeutics Inc and Pfizer Inc said on Wednesday they would work together to develop a gene therapy to treat ALS
- Source: Reuters
- 541
- January 4, 2018
ALS Company Insight FDA Gene therapy Pfizer
Scholar Rock scoops $47M to trial SMA drug

Scholar Rock has raised $47 million to take its treatment for spinal muscular atrophy (SMA) into the clinic. The series C tees up Scholar Rock to find out whether its myostatin blocker can best the underwhelming performance of one-time rivals from companies including Novartis.
- Source: fiercebiotech
- 543
- January 4, 2018
blocker Company Insight myostatin SMA
How to Keep Health Data Safe in the Age of Disruptive Technologies

The health system has developed AI-based algorithms used on its more than 27 petabytes of data to define patient subpopulations — those with congestive heart failure or asthma, for instance — to target interventions to those groups. It’s developed algorithms using electronic health record data to predict patient decline in hospitals.
- Source: HealthTech Magazine
- 623
- January 4, 2018
AI blockchain disruptive technology healthcare technology Market Views
After disappointing 2016, new drug approvals roared back to life in 2017

New drug approvals all but screeched to a halt in 2016, with a measly 22 new OKs after a pair of bountiful years. But the FDA wasted no time in 2017, signing off on 12 drugs in the first quarter alone—besting its record for the same period of any year in recent history.
- Source: fiercebiotech
- 668
- January 4, 2018
CAR-T therapy FDA New Approvals new drug
In boost to Abbott, spinal-cord implants emerge as alternative to pills

Recent innovations from global device makers like Abbott to smaller specialists such as Nevro Corp. made the implants more powerful and effective. Combined with a national crackdown on narcotics and wanton pain pill prescriptions, they are spurring demand for implants.
- Source: Crain's Chicago Business
- 617
- January 4, 2018
Abbott Company Insight healthcare technology medtech nerve cell opioid
Scientists Unveil the First Portable Bionic Hand With a Sense of Touch

The first portable bionic hand restores the sense of touch in people who lost their limbs. Although the hand is still a prototype, we're one step closer to the day when a fully natural, sensorized prosthesis will be available.
- Source: Futurism
- 491
- January 4, 2018
Company Insight digital health healthcare technology medtech
Starting new COPD inhaler tied to heart attack risk

People with chronic obstructive pulmonary disease (COPD) who use long-acting inhaled bronchodilators may have an increased risk of heart attacks and strokes right after they start taking these medicines, a Taiwanese study suggests.
- Source: Reuters
- 582
- January 3, 2018
COPD heart attacks Researches stroke
FDA Approves Angiotensin-II for Septic Shock

The FDA approved angiotensin-II (Giapreza) as a new intravenous vasopressor for septic shock and other forms of distributive shock. The first new FDA-approved vasopressor in decades, angiotensin-II could significantly change the management of severe septic shock.
- Source: PulmCCM
- 572
- January 3, 2018
FDA New Approvals sepsis septic shock

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.